![[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth](https://www.europesays.com/ch/wp-content/uploads/2026/02/84b0110bbf60eb8397db0461bc3549c4-380x220.png)
European Commission approves Roche’s Gazyva/Gazyvaro for adults with active lupus nephritis
F. Hoffmann-La Roche Ltd Approval based on phase II NOBILITY and phase III REGENCY studies showing superiority of…
Browsing Tag